Table 1.
Characteristics of study population
| Entire sample (N = 76) |
Sample included in the analysis (N = 65) |
|||
|---|---|---|---|---|
| Sociodemographics | n | % | n | % |
| Race/ethnicity | ||||
| White | 31 | 41 | 29 | 45 |
| Latina/Hispanic | 27 | 36 | 19 | 29 |
| African American/Black | 11 | 14 | 11 | 17 |
| Asian/Pacific Islander | 3 | 4 | 3 | 5 |
| Multiethnic/other | 4 | 5 | 3 | 5 |
| Completed interview in Spanish | 26 | 34 | 17 | 26 |
| Age (mean, SD) | 38.4 | 11 | 38.8 | 11 |
| < 25 | 6 | 8 | 5 | 8 |
| 25-29 | 18 | 24 | 15 | 23 |
| 30-39 | 17 | 22 | 14 | 22 |
| 40-49 | 22 | 29 | 19 | 29 |
| 50-64 | 13 | 17 | 12 | 18 |
| Born in the United States | 54 | 71 | 50 | 77 |
| Educational attainment | ||||
| ≤ High school graduate | 18 | 24 | 11 | 17 |
| Some college | 21 | 28 | 20 | 31 |
| College graduate | 26 | 34 | 24 | 37 |
| Graduate school | 11 | 14 | 10 | 15 |
| Income | ||||
| ≤$25,000 | 22 | 29 | 14 | 22 |
| $25,001-$50,000 | 27 | 36 | 25 | 38 |
| $50,001-$100,000 | 17 | 22 | 17 | 26 |
| > $100,000 | 7 | 9 | 7 | 11 |
| Unsure | 3 | 4 | 2 | 3 |
| Married or living with partner | 38 | 51 | 32 | 50 |
| Insurance status | ||||
| Medi-Cal | 14 | 18 | 11 | 17 |
| Kaiser | 18 | 24 | 17 | 26 |
| Other private insurance or HMO | 23 | 30 | 23 | 35 |
| Medicare | 2 | 3 | 2 | 3 |
| Other | 6 | 8 | 4 | 6 |
| Unsure | 3 | 4 | 3 | 5 |
| None | 13 | 17 | 8 | 12 |
| Prior tests or treatments for dysplasia | ||||
| Colposcopy | 68 | 89 | 60 | 92 |
| LEEP | 19 | 25 | 17 | 26 |
| Cryotherapy | 8 | 11 | 8 | 13 |
| Cone biopsy | 5 | 7 | 4 | 6 |
| Hysterectomy | 0 | 0 | 0 | 0 |
| Positive HPV test* | 34 | 46 | 29 | 46 |
| Health-related quality of life † | 48.3 | 11.5 | 49.2 | 11.0 |
| PCS (SF-12; mean, SD) | ||||
| MCS (SF-12; mean, SD) | 45.8 | 10.4 | 46.0 | 10.8 |
| Cancer worry (mean, SD)‡ | 5.6 | 2.5 | 5.4 | 2.0 |
SD, standard deviation; HMO, health maintenance organization; LEEP, loop electrosurgical excision procedure; HPV, human papillomavirus; SF, short-form; PCS, Physical Component Summary; MCS, Mental Component Summary. All numbers are n (%) unless otherwise noted.
*
We only asked participants whether or not they had had a positive HPV test.
†
Scale ranges from 1 to 100, with higher scores denoting better physical and mental health.
‡
Scale adapted from four-item Cancer Worry Scale developed by Lerman et al.(10) For each item, scores range from 4 to 16, with higher scores denoting more worry.